Jack Kaye, Director at KERYX BIOPHARMACEUTICALS INC (KERX), bought 1,400 shares at $10.50 ($15K) on 2007-06-19, disclosed to the SEC on 2007-06-22.
Open-market purchase of $15k KERX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| QURE | SELL | 2026-06-12 | $54K | — | Filing → |
| QURE | SELL | 2026-06-05 | $79K | — | Filing → |
| QURE | SELL | 2026-01-12 | $174K | — | Filing → |